Incubation in the presence of structurally modified disaccharides altered the in vitro attachment of Yersinia pestis GB to three human respiratory epithelial cell lines. Each disaccharide resulted in decreased attachment to the alveolar epithelial (A549) cell line. The best inhibitor of attachment for each cell line was the benzylated derivative of Galb1-4GalNAc. Highly negatively charged saccharides were efficient inhibitors, particularly for the bronchial epithelial (BEAS2-B) cell line. The data indicate that targeted modification of receptor ligands could offer a novel therapeutic preventing Y. pestis attachment to host cells.
Introduction
Yersinia pestis is the causative agent of plague represented clinically as the typical bubonic form. However, involvement of the respiratory tract can result in pneumonic plague, an aggressive manifestation that is less easily treated and permits person-to-person transmission (Perry & Fetherston, 1997; Krishna & Chitkara, 2003) . This characteristic has led to plague being listed as an agent of concern regarding bioterrorism. Present treatment involves administration of antibiotics such as doxycycline or ciprofloxacin; however, the therapeutic window is small as any delay in diagnosis rapidly reduces effectiveness against pneumonic plague (Inglesby et al., 2000) .
Many bacteria attach to oligosaccharides located on glycolipids and glycoproteins inserted into the host cell membrane. These interactions are often specific, providing a novel method to interfere in the host-pathogen relationship (Zopf & Roth, 1996; Sharon & Ofek, 2002) . Previous studies have demonstrated the ability of Y. pestis to attach to oligosaccharide structures located on human respiratory cell lines. Inhibition of attachment to respiratory epithelial cell lines was achieved using a range of compounds, although inhibition did not exceed 60% using saccharides (Thomas & Brooks, 2004a , 2006 . Structural modification of base oligosaccharides (e.g. halogenation, sulphation, benzylation) offers a novel mechanism to generate better antiadhesion compounds. Modifications may alter the binding affinity of the oligosaccharides for specific adhesins and hence increase the effectiveness as an antiadhesion therapeutic. Such a strategy has been employed with success in Pseudomonas aeruginosa PAK (Schweizer et al., 1997) . The present study assessed structural variants of galactosucrose for their ability to inhibit Y. pestis adhesion to a range of human respiratory cell lines. To our knowledge, this is the first study to investigate the potential for structural modifications of saccharides to inhibit Y. pestis attachment to host cells.
Materials and methods

Materials
Tissue culture reagents and para-nitrophenol were purchased from Sigma-Aldrich Company Ltd, UK. Saccharides were synthesized by Dextra Laboratories Ltd, Reading, UK.
Bacterial growth conditions
Yersinia pestis GB was part of the site culture collection. The bacteria were routinely cultured as previously described under Category 3 containment (Thomas & Brooks, 2006) .
Culture of cell lines
The cell lines used were historically derived from the alveolar epithelium (A549), bronchial epithelium (BEAS2-B) and nasal epithelium (RPMI-2650). The A549 cell line was obtained from the European Collection of Cell Cultures (ECACC), Health Protection Agency (HPA), Porton Down, Wiltshire, UK. The BEAS2-B and RPMI-2650 cell lines were obtained from the American Type Culture Collection (ATCC), Manassas, Virginia. Adherent A549 and BEAS2-B cells were cultured in tissue culture flasks containing Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) fetal calf serum (FCS) and 2 mM glutamine. Adherent RPMI-2650 cells were cultured in tissue culture flasks containing Eagle's modified essential medium (EMEM) supplemented with 10% (v/v) FCS, 2 mM glutamine and 1% (v/v) nonessential amino acids. The cells were incubated at 37 1C in an atmosphere of 5% (v/v) CO 2 and split 1:3 every 3-4 days. For the purpose of adhesion assays, the cells were rinsed twice with prewarmed phosphatebuffered saline (PBS) before incubation in the presence of trypsin-0.05% (w/v) EDTA solution in PBS. After removal of the trypsin solution, the cells were resuspended in warm fresh medium, seeded in 96-well microtitre plates to a density of 50 000 cells per well in 100 mL medium, and incubated overnight as previously described to produce confluent monolayers for the adhesion assay.
Adhesion assay
Confluent monolayers in 96-well microtitre plates were washed five times with 150 mL PBS prewarmed to 37 1C. Nonspecific binding was blocked by incubation for 1 h at 37 1C with 0.5% (w/v) bovine serum albumin before rinsing twice with prewarmed PBS. Bacteria at a density of 10 7 CFU mL À1 were incubated for 1 h at room temperature in a 1:1 ratio with the antiadhesion compound to provide a final concentration of 0.1, 0.5, 1.5 or 3.0 mM ( Table 1) . The relevant concentrations were prepared in tissue culture medium prewarmed to 37 1C. Controls were always performed with no saccharide. Wells containing no eukaryotic cells were used to determine background binding to plates. A 100-mL volume of the bacteria-saccharide solution was added to the cell monolayer and incubated for 1 h at 37 1C. Nonadherent bacteria were removed from the monolayers by rinsing five times with prewarmed PBS. The cells were lysed by incubation for 30 min at 37 1C with a 0.1% (v/v) Triton-X100 solution in PBS. Serial dilutions were performed in PBS and 100-mL volumes of the lysate plated in duplicate on to the blood agar base (BAB) plates and incubated at 28 1C for 48 h. The percentage inhibition was calculated by the equation:
Cytotoxicity assay
The CellTiter 96 s Non-Radioactive Cell Proliferation Assay (Promega) was used for all cytotoxicity assays in accordance with the manufacturer's instructions (Thomas & Brooks, 2004b) .
Statistical analysis
All experiments were performed as three independent assays. Assays were performed in triplicate per experimental run. Results are expressed as the mean value and SDs are provided where appropriate. P-values were calculated using paired t-tests.
Results and discussion
In a previous study, it was observed that a number of compounds inhibited attachment of Y. pestis to a range of respiratory cell lines to various degrees. The greatest inhibition was observed with the hydrophobic compound paranitrophenol. The best oligosaccharides were GalNAcb1-3Gal and GalNAcb1-4Gal (Thomas & Brooks, 2004a , 2006 . The inherent low binding affinity of monovalent saccharideprotein interactions reduces the therapeutic value of such compounds in vivo where clearance mechanisms within the lung would reduce the local saccharide concentration. Indeed, the natural occurrence of multivalent interactions between multiple saccharides and adhesins produces binding affinities many orders of magnitude higher than monovalent interactions (Adler et al., 1995; Brewer et al., 2002) . Furthermore, receptor redundancy due to the presence of multiple adhesins on the bacterial surface means that mixtures of antiadhesion compounds targeted to specific adhesins or a multivalent approach would be a better mechanism for preventing infections by oligosaccharide therapy (Autar et al., 2001) . This strategy requires detailed knowledge of the molecular pathogenesis of pneumonic plague. At present, this strategy is limited due to the paucity of information regarding the adhesins important for development of either bubonic or pneumonic plague. An alternative strategy would be to modify compounds structurally to increase the binding affinity for adhesins. This has previously been attempted; structural modifications of GalNAcb1-4Gal demonstrated different binding affinities for the pili of P. aeruginosa (Schweizer et al., 1997) . In this study, a series of modified saccharides based on galactosucrose (PDX019) were used to assess the potential of oligosaccharide modification to produce better inhibitors of Y. pestis attachment to respiratory cell lines. The structures of the compounds used are shown in Fig. 1 . Modification of the galactosucrose structure produced significant differences in the ability to inhibit Y. pestis attachment to various cell lines (Table 2 ; Fig. 2 ). This was particularly noticeable in the A549 cell line where each modification resulted in increased inhibition of attachment by at least 10-fold compared with galactosucrose. None of the saccharides tested was cytotoxic towards the cell lines at the concentration used in the assay. In addition, none of the compounds was inhibitory at the concentrations used towards the bacteria (data not shown).
The base compound galactosucrose (PDX019) was ineffective in preventing attachment to both the A549 and the RPMI-2650 cell lines (3% and 23%, respectively); however, inhibition of attachment to the BEAS2-B cell line (66%) was significantly different (P = 0.023). As galactosucrose was such a poor inhibitor in the A549 cell line (3%), every modified saccharide had significantly greater antiadhesion activity, the best being PDX327 ( Table 2 ). All of the modified saccharides, with the exception of PDX039 and 143/87/72B, were better inhibitors of Y. pestis attachment to the RPMI-2650 cell line than galactosucrose (PDX019). However, only MJQ 156/85/14 of the modified disaccharides demonstrated significantly better inhibition in the BEAS2-B cell line (P = 0.007) although inhibition was at an equivalent level to that obtained with p-nitrophenol. The saccharides demonstrated dose-dependent inhibition across the concentration range of 0-3.0 mM (Fig. 2) . Due to the relatively low concentration range examined, only the most effective inhibitors demonstrated saturation of the receptor sites at 3.0 mM. As expected from Table 2 , p-nitrophenol showed saturation for inhibition of attachment at 1.5-3.0 mM for each cell line. Only one other compound reached saturation over the concentration range, MJQ 156/85/14 in the BEAS2-B cell line. Extrapolation indicates that for the majority of the compounds the concentration required to achieve 100% inhibition exceeded 10 mM. The best inhibitor for the A549 cell line was the benzylbased oligosaccharide (Galb1-4GalNAc) PDX327 (69%), which inhibited adhesion to similar levels as that observed with p-nitrophenol (73%) at 1.5 mM. However, although PDX327 was one of the better inhibitors in the RPMI-2650 and BEAS2-B cell lines it never exceeded the levels obtained with p-nitrophenol in the respective cell lines. It appears that the hydrophobic benzyl group present in both PDX327 and p-nitrophenol is a useful inhibitor of Y. pestis attachment. This structure has also proved an effective inhibitor of attachment in other respiratory pathogens (Thomas & Brooks, 2004a,b) and intestinal pathogens such as Escherichia coli to their respective tissue types (Falkowski et al., 1986) . Regarding the other modified saccharides, only MJQ 156/85/14 had increased antiadhesion activity across all the cell lines. This compound is highly negatively charged due to three chlorine atoms and five chlorosulphate groups. It has previously been hypothesized that charge plays a role in Chlamydia trachomatis adhesin-receptor interactions (Zaretzky et al., 1995) . Interestingly, the negatively charged polysaccharides heparin and dextran sulphate have previously been shown to be effective inhibitors of Y. pestis attachment to these cell lines, heparin being the far more effective (Thomas & Brooks, 2004a , 2006 . The inhibitory activity of these saccharides is probably dual, including specific interactions resulting from the structure of the saccharide and the negative charge, and also nonspecific Table 2 ). The replacement of the chlorine atom with a bromine atom in P3/143/96 increased the inhibitory activity from 15.0% to 50.3%, probably by increasing affinity for a specific unidentified adhesin.
This study is the first to our knowledge that has investigated the principle of structural modification of an oligosaccharide moiety to alter antiadhesion activity with respect to Y. pestis attachment. Evidence is provided using structural variants of galactosucrose that such an approach could be successful in the development of inhibitors of Y. pestis attachment. However, for such an approach to be successful, it is evident that the base compound would have to be carefully selected and would require detailed knowledge of the adhesin(s) with which the saccharide interacts. The best saccharide candidate identified to date is GalNAcb1-4Gal (Thomas & Brooks, 2004a , 2006 . The adhesins chosen would need to be important for colonization of the respiratory tissues during the progression of pneumonic plague.
